White Papers & Case Studies

The opioid epidemic is one of the most pressing and prevalent issues that our great nation faces. More than 33,000 people lost their lives to opioids in 2015, and the Surgeon General reports that substance misuse and SUD costs society $442 billion each year.

This guide discusses how we can improve clinical and financial outcomes for those with Substance Use Disorder through a combination of post-acute engagement, upstream prevention, emerging technologies, and data analysis.

Since 2011, MAP's internal care management team has engaged in over 200,000 post-acute telehealth sessions and all functions of collaborative, post-acute care. Over the course of the last six years of gathering data and following persons in recovery from addiction and/or Substance Use Disorder longitudinally, MAP Clinical teams have identified some important factors in determining the potential risk of a use event, relapse, or return to active addiction.

In order to successfully transition to pay-for-performance models in the new healthcare paradigm, behavioral healthcare providers must be prepared to answer 10 critical questions. This white paper addresses these questions, and the answers. MAP’s Data Experts distill their knowledge and experience to share innovative ways to optimize Behavioral Health Population Management treatment outcomes and care models.

The paper showcases the rapid evolvement of the Austin based, data-driven company which has taken empirical outcomes data, interpreted the results, and has begun to demonstrate effective means in which treatment providers can extend the care continuum for discharged patients rendering successful treatment results. The data demonstrated by MAP has sparked the attention of major health insurance payers motivated to contain the rising costs of increased recidivism in addiction treatment and who have begun to express interest in reimbursing providers for extending the care continuum.